vascuCAP vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (vascuCAP) focuses on quantifying plaque composition and characterizing its features from CT angiography to assess cardiovascular risk, including specific plaque components. Tool B (FFRct) utilizes AI and computational fluid dynamics to analyze blood flow in coronary arteries from CCTA scans, aiding in the diagnosis of coronary artery disease and guiding revascularization decisions by evaluating the functional significance of arterial narrowing. While both leverage CCTA for cardiovascular assessment, vascuCAP provides insights into plaque vulnerability, whereas FFRct evaluates the hemodynamic impact of stenoses.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
vascuCAP (now ElucidVivo/PlaqueIQ) primarily focuses on quantifying plaque composition and assessing cardiovascular risk for stroke and heart attack using non-invasive CT angiography analysis. FFRct, on the other hand, is designed to assess blood flow in coronary arteries from CCTA scans to aid in diagnosing coronary artery disease.
vascuCAP utilizes AI-enabled CT angiogram analysis for histologically-validated plaque quantification and characterization, including lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage. FFRct employs AI and computational fluid dynamics (CFD) to create personalized 3D models of coronary arteries and analyze blood flow, identifying areas of narrowing with FFRct values.
vascuCAP provides quantification of various plaque components and 3D visualization of arterial vessels and plaque to support personalized treatment decisions and risk stratification. FFRct generates personalized 3D digital models of coronary arteries and FFRct values, integrating anatomical and physiological data from CCTA to help guide treatment strategies and revascularization decisions.
vascuCAP is designed for use in Cardiology, Radiology, and Vascular Surgery. FFRct is primarily intended for Cardiology and Radiology specialties.
vascuCAP focuses on risk stratification for stroke and heart attack by characterizing plaque composition. FFRct aids in diagnosing coronary artery disease by assessing the physiological impact of blockages on coronary blood flow.